Abstract
The ETS family of transcription factors is known to play important roles in various biological processes such as development, differentiation, proliferation, apoptosis, migration, tissue remodeling, invasion and angiogenesis in various cell types including B cells, endothelial cells, fibroblasts as well as diverse neoplastic cells. In prostate cancer, recurrent gene fusions involving members of the ETS family are frequently reported. ETS-1, the prototype of the ETS family, is expressed in different cell types and is known to play various roles during both physiological and pathological conditions. In this review, we focus on studies investigating the role of ETS-1 in prostate cancer.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Cell Movement
-
Gene Expression
-
Humans
-
Male
-
Oncogene Proteins, Fusion / genetics
-
Oncogene Proteins, Fusion / metabolism*
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / metabolism*
-
Prostatic Neoplasms / pathology
-
Proto-Oncogene Protein c-ets-1 / genetics
-
Proto-Oncogene Protein c-ets-1 / metabolism*
-
Serine Endopeptidases / genetics
-
Serine Endopeptidases / metabolism
-
Trans-Activators / genetics
-
Trans-Activators / metabolism
-
Transcriptional Regulator ERG
Substances
-
ERG protein, human
-
ETS1 protein, human
-
Oncogene Proteins, Fusion
-
Proto-Oncogene Protein c-ets-1
-
Trans-Activators
-
Transcriptional Regulator ERG
-
Serine Endopeptidases
-
TMPRSS2 protein, human